STOCK TITAN

TPG reports 6.7% Jackson Financial (JXN) stake in Schedule 13G

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

TPG GP A, LLC and related individuals reported a significant passive stake in Jackson Financial Inc. through a Schedule 13G filing. The group may be deemed to beneficially own 4,715,554 shares of common stock, representing 6.7% of the class, based on 70,816,945 shares outstanding as of February 11, 2026.

The shares are held directly by TPG Operating Group II, L.P., over which TPG GP A exercises control, while James G. Coulter and Jon Winkelried may be deemed to share beneficial ownership through their relationship to TPG GP A. They certify the securities were not acquired to change or influence control of Jackson Financial.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: The percentage beneficial ownership set forth in response to Item 11 above is based on a total of 70,816,945 shares of Common Stock (as defined below) outstanding as of February 11, 2026, based on information provided by the Issuer (as defined below).


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage beneficial ownership set forth in response to Item 11 above is based on a total of 70,816,945 shares of Common Stock outstanding as of February 11, 2026, based on information provided by the Issuer.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage beneficial ownership set forth in response to Item 11 above is based on a total of 70,816,945 shares of Common Stock outstanding as of February 11, 2026, based on information provided by the Issuer.


SCHEDULE 13G



TPG GP A, LLC
Signature:/s/ Martin Davidson
Name/Title:Martin Davidson / Chief Accounting Officer
Date:02/13/2026
COULTER, JAMES G
Signature:/s/ Gerald Neugebauer
Name/Title:Gerald Neugebauer, on behalf of James G. Coulter (1)
Date:02/13/2026
WINKELRIED JON
Signature:/s/ Gerald Neugebauer
Name/Title:Gerald Neugebauer, on behalf of Jon Winkelried (2)
Date:02/13/2026

Comments accompanying signature: (1) Gerald Neugebauer is signing on behalf of Mr. Coulter pursuant to an authorization and designation letter dated January 10, 2024, which was previously filed with the Commission as an exhibit to a Form 4 filed by Mr. Coulter on February 7, 2024 (SEC File No. 001-41617). (2) Gerald Neugebauer is signing on behalf of Mr. Winkelried pursuant to an authorization and designation letter dated January 10, 2024, which was previously filed with the Commission as an exhibit to a Form 4 filed by Mr. Winkelried on February 7, 2024 (SEC File No. 001-41617).
Exhibit Information

Exhibit 1 - Agreement of Joint Filing as required by Rule 13d-1(k)(1) under the Act.* _______________ * Incorporated herein by reference to the Agreement of Joint Filing by TPG Group Holdings (SBS) Advisors, Inc., TPG GP A, LLC, TPG Advisors VII, Inc., TPG Advisors VI, Inc., TPG Advisors VI-AIV, Inc., TPG Asia Advisors VI, Inc., David Bonderman, James G. Coulter, Jon Winkelried and Karl Peterson dated as of January 18, 2022, which was previously filed with the Securities and Exchange Commission (the "Commission") as Exhibit 1 to Amendment No. 4 to Schedule 13D filed by TPG GP A, LLC, David Bonderman, James G. Coulter and Jon Winkelried on January 18, 2022 with respect to the shares of common stock of Allogene Therapeutics, Inc.

FAQ

What ownership stake in Jackson Financial (JXN) is reported in this Schedule 13G?

The filing reports beneficial ownership of 4,715,554 Jackson Financial common shares, representing 6.7% of the outstanding class. This percentage is based on 70,816,945 shares of common stock outstanding as of February 11, 2026, using issuer-provided information.

Who are the reporting persons in the Jackson Financial (JXN) Schedule 13G?

The Schedule 13G is filed jointly by TPG GP A, LLC, James G. Coulter, and Jon Winkelried. They file under a joint filing agreement and may be deemed to share beneficial ownership of the same 4,715,554 Jackson Financial common shares held through the TPG structure.

How are the Jackson Financial (JXN) shares held by the reporting group?

The 4,715,554 Jackson Financial common shares are held directly by TPG Operating Group II, L.P.. TPG GP A exercises control over entities that ultimately control this partnership, and Coulter and Winkelried may be deemed to beneficially own the shares through their interests in TPG GP A.

Do the reporting persons intend to influence control of Jackson Financial (JXN)?

The reporting persons certify the shares were not acquired and are not held for the purpose of changing or influencing control of Jackson Financial. They also state the holdings are not in connection with any transaction having that purpose or effect, consistent with a passive investment filing.

What voting and dispositive powers are reported over Jackson Financial (JXN) shares?

Each reporting person shows 0 shares with sole voting or dispositive power and 4,715,554 shares with shared voting and shared dispositive power. This reflects coordinated control over how these Jackson Financial common shares may be voted and disposed of through the TPG structure.

Where are the principal business offices of the Jackson Financial (JXN) reporting persons?

The principal business address for each reporting person is listed as c/o TPG Inc., 301 Commerce Street, Suite 3300, Fort Worth, Texas 76102. Jackson Financial’s own principal executive offices are at 1 Corporate Way, Lansing, MI 48951, as stated separately in the filing.
Jackson Financial Inc

NYSE:JXN

JXN Rankings

JXN Latest News

JXN Latest SEC Filings

JXN Stock Data

7.62B
66.44M
1.73%
95.56%
4.06%
Insurance - Life
Life Insurance
Link
United States
LANSING